A delayed diagnosis is common for people with acquired hemophilia A (AHA), according to a new study that found that it took more than a month to get a diagnosis after the first bleeding episode for about 1 in 3 patients. Despite these delays, all AHA patients in the…
Search results for:
People with bleeding disorders face a variety of challenges. Healthcare access is a constant concern and covers myriad issues, including political and financial stability and regulatory and provider awareness. Most of us spend a fair amount of time educating and advocating for these issues. One thing we don’t often talk…
The current state of our world has me longing for something. It’s something that when gone, nothing remains quite the same. What I long for is routine. Yes, I miss the humdrum and the mundaneness of routine. I can still count on some aspects of my life remaining steady, such…
The favorite Winter Olympics sport in my home is figure skating. My husband can tell you who won which medal in any Olympic games, and when he hears a piece of music that was used by a skater, he can not only tell you the name of the…
What Is Prophylaxis?
Prophylaxis is the term used for the infusion of clotting factor (proteins in the blood which help to stem blood flow) for people living with severe hemophilia. This is a preventative measure to avoid bleeds should the patient injure themselves and can also be taken after a bleed to lessen…
Knowing when to stay and when to switch providers can shape your hemophilia care journey. Learn how to spot red flags, navigate tough conversations, and advocate for a care team that truly works with you.
Switching to Rebinyn (nonacog beta pegol) from other standard or extended half-life replacement therapies led to “robust” reductions in annual treatment costs among hemophilia B patients in Canada, a study based on real-world data reported. Its findings add to an earlier and real-world analysis of patients who…
Believe Limited, continuing a partnership with BioMarin Pharmaceutical and working with the Foundation for Art & Healing, announced plans to produce a documentary film on the everyday challenges and victories of living with a bleeding disorder. The digital content production company, again with the support of BioMarin, produced “…
I grew up believing that it was impossible for a hemophilia carrier who was also a woman to manifest the condition. I had stitches five times before the age of 5. I limped through elementary school, in pain from physical education classes. I…
A single dose of Roctavian (valoctocogene roxaparvovec-rvox) nearly zeroed out the number of bleeds and the need for prophylaxis, or preventive therapy, for as long as seven years — the longest follow-up to date for any hemophilia A gene therapy clinical trial. While most of the 12 patients…